• LAST PRICE
    1.5200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.4400/ 4
  • Ask / Lots
    1.5600/ 10
  • Open / Previous Close
    1.4700 / 1.5200
  • Day Range
    Low 1.4700
    High 1.5300
  • 52 Week Range
    Low 1.3800
    High 11.3200
  • Volume
    24,693
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.5
TimeVolumeDNAY
09:32 ET1091.47
09:33 ET3001.5
09:35 ET1001.5
10:06 ET10001.501
10:09 ET15001.4806
10:15 ET2301.485
10:56 ET6731.485
11:34 ET15001.4878
11:48 ET2001.48
11:59 ET59571.49
12:08 ET44141.5
12:39 ET7021.53
12:46 ET1001.5
01:00 ET35261.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDNAY
Telesis Bio Inc
44.9M
-0.8x
---
United StatesMLSS
Milestone Scientific Inc
42.3M
-5.4x
---
United StatesMDGS
Medigus Ltd
55.7M
-1.9x
---
United StatesBTCY
Biotricity Inc
51.2M
-2.2x
---
United StatesEKSO
Ekso Bionics Holdings Inc
15.2M
-1.0x
---
United StatesPRPO
Precipio Inc
17.5M
-1.4x
---
As of 2022-11-28

Company Information

Telesis Bio Inc., formerly Codex DNA, Inc., is a synthetic biology company, which is focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA). Its synthetic biology solution addresses bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. The Company's products include BioXp systems, including BioXp 3250 system, BioXp kits for generating a range of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. It has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. It has placed approximately 200 BioXp systems globally.

Contact Information

Headquarters
9535 Waples Street, Suite 100SAN DIEGO, CA, United States 92121-2993
Phone
858-228-4115
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
Franklin Witney
President, Chief Executive Officer, Director
Todd Nelson
Chief Financial Officer
Jennifer Mcnealey
Chief Technology Officer
Daniel Gibson
Independent Director
Andrea Jackson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$44.9M
Revenue (TTM)
$21.0M
Shares Outstanding
29.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.80
Book Value
$3.10
P/E Ratio
-0.8x
Price/Sales (TTM)
2.1
Price/Cash Flow (TTM)
---
Operating Margin
-244.37%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.